Horizons in the Pharmacotherapy of Obesity

Current Obesity Reports
J R Arch

Abstract

Obesity drugs have had a chequered history. In the recent past, only the low efficacy, pancreatic lipase inhibitor orlistat was available worldwide and it was little used. The 5HT2C agonist, lorcaserin, and two combinations of old drugs have been approved in the United States but not in Europe. The diabetes drug liraglutide has been approved in both the US and Europe and seems likely to be most widely accepted. In view of regulators' caution in approving obesity drugs, some (like beloranib) may initially be progressed for niche obesity markets. New drug targets have been identified in brown adipose tissue with the aim of not only activating thermogenesis but also increasing the capacity for thermogenesis in this tissue. Attempts are being made to match the efficacy of bariatric surgery by mimicking multiple gut hormones. Unapproved pharmacotherapies are tempting for some patients. Others remain optimistic about more conventional routes to pharmacotherapy.

References

Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·O ChampignyB R Holloway
Jun 17, 1998·The Journal of Clinical Investigation·M H FisherD E MacIntyre
Nov 25, 1998·Biochemical and Biophysical Research Communications·V EmilssonM A Cawthorne
Jan 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yanqiao ZhangPeter A Edwards
Sep 6, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P KopelmanP Valensi
Jun 19, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mohiuddin HadiJorge A Carrasquillo
Jul 27, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A Golay
Nov 17, 2007·BMJ : British Medical Journal·Diana RuckerDavid C W Lau
Apr 11, 2008·The American Journal of Clinical Nutrition·Arnaud ChioleroJacques Cornuz
Dec 6, 2008·The American Journal of Clinical Nutrition·Soren SnitkerMichio Takahashi
Apr 10, 2009·The New England Journal of Medicine·Kirsi A VirtanenPirjo Nuutila
Nov 6, 2009·Advances in Therapy·Coleman GrossJoseph K Belanoff
Apr 24, 2010·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Cherry Wyant JacksonRaymond Lorenz
Nov 11, 2010·The Journal of Clinical Psychiatry·Alessandro Serretti, Laura Mandelli
Feb 3, 2011·British Journal of Clinical Pharmacology·Samir Kumar PraharajVinod Kumar Sinha
Apr 26, 2011·Pharmacology & Therapeutics·John C Clapham, Jonathan R S Arch
Aug 30, 2011·Lancet·Kevin D HallBoyd A Swinburn
Feb 9, 2012·Diabetes·Pablo B Martínez de MorentinMiguel López
May 10, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Laura PiccoliMauro Corsi
Aug 24, 2012·Disease Models & Mechanisms·R John RodgersJohn P H Wilding
Jul 3, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·T A WaddenUNKNOWN NN8022-1923 Investigators
Jul 13, 2013·The American Journal of Psychiatry·L Fredrik JarskogUNKNOWN METS Investigators
Jul 23, 2013·The Journal of Clinical Investigation·Takeshi YoneshiroMasayuki Saito
Aug 24, 2013·Diabetes, Obesity & Metabolism·M ChiltonL J Gray
Aug 24, 2013·BMJ : British Medical Journal·Sidney M Wolfe
Sep 10, 2013·Cell Metabolism·Gregory GaichDavid E Moller
Sep 11, 2013·Pharmacotherapy·Christian HamppVicky Borders-Hemphill
Nov 12, 2013·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A D Miras, C W le Roux
Nov 15, 2013·Obesity·Harold E BaysWilliam Canovatchel
Nov 16, 2013·JAMA : the Journal of the American Medical Association·Susan Z Yanovski, Jack A Yanovski
Jan 2, 2014·Therapeutic Advances in Chronic Disease·Rachel C TrokeSteve R Bloom
Jan 28, 2014·Expert Opinion on Emerging Drugs·Deborah L Reas, Carlos M Grilo
Jan 28, 2014·Trends in Endocrinology and Metabolism : TEM·Wouter van Marken LichtenbeltLisje Schellen

❮ Previous
Next ❯

Citations

Feb 26, 2016·The Journal of Endocrinology·Martina HolubováLenka Maletínská
Jul 16, 2016·The Journal of Endocrinology·Jaroslav KunešLenka Maletínská
Apr 5, 2018·Current Obesity Reports·Angel S ByrdFatima Cody Stanford
Dec 14, 2017·Journal of Molecular Endocrinology·Martina HolubováBlanka Železná
Apr 4, 2019·The Journal of Pharmacology and Experimental Therapeutics·Lei HaoShu Wang
Aug 1, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xiaobing ZhangWeidong Xie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
T B SeatonR G Campbell
Journal of Physiology, Paris
L Girardier, J Seydoux
Biochemical Society Transactions
D NichollsH Wiesinger
© 2021 Meta ULC. All rights reserved